Search
for

    Sort by

    Research 91–120 of 1000+

    1. The influence of obesity on Androstenedione to Testosterone ratio in women with polycystic ovary syndrome (PCOS) and hyperandrogenemia Gynecological Endocrinology · 2011 · 15 citations
    2. Bone Mineral Density is Unaltered in Women with Polycystic Ovary Syndrome Hormone and Metabolic Research · 2018 · 11 citations
    3. The differences between aromatizable and non-aromatizable androgens in relation to body composition and metabolic syndrome risk factors in men The Journal of Steroid Biochemistry and Molecular Biology · 2012 · 8 citations
    4. The Possibilities of Using Chromium Salts as an Agent Supporting Treatment of Polycystic Ovary Syndrome Biological Trace Element Research · 2019 · 4 citations
    5. Evaluation of metabolic and hormonal parameters in women with PCOS living in Black Sea Region 2021 · 1 citations
    6. Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society The Journal of Clinical Endocrinology & Metabolism · 2010 · 815 citations
    7. Prevalence of Metabolic Syndrome in Patients with Mucosal Lichen Planus: A Case–Control Study American Journal of Clinical Dermatology · 2015 · 28 citations
    8. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Human Reproduction · 2003 · 4025 citations
    9. Diagnosing polycystic ovary syndrome Women's Health Medicine · 2006 · 2 citations
    10. Clinical Utility of GnRH Analogues in Female Androgen Excess: Highlighting Diagnostic and Therapeutic Applications JCEM case reports · 2023 · 1 citations
    11. Controversies in Polycystic Ovary Syndrome InTech eBooks · 2018
    12. Ameliorative Impact of High Inositol Diet on the Insulin Resistance and Metabolite Hormones among Women with Polycystic Ovary Syndrome Maǧallaẗ Buḥūṯ Al-Tarbiyyaẗ Al-Nawʿiyyaẗ (Print) · 2022
    13. Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient International journal of reproduction, contraception, obstetrics and gynecology · 2017 · 3 citations
    14. The effects of pro-, pre- and synbiotics supplementation on polycystic ovary syndrome: an umbrella review of meta-analyses of randomized controlled trials Research Square (Research Square) · 2022
    15. Evaluation Asprosin Level in Polycystic Ovary Syndrome and Its Association with Fetuin a and Some Biochemical Parameter South Asian Research Journal of Pharmaceutical Sciences · 2023 · 1 citations
    16. Cutaneous Manifestations and Their Relationship with Serum Testosterone and DHEAS Levels in Women with Polycystic Ovary Syndrome: A Cross‑Sectional Clinical Study Zenodo (CERN European Organization for Nuclear Research) · 2026
    17. Cutaneous Manifestations and Their Relationship with Serum Testosterone and DHEAS Levels in Women with Polycystic Ovary Syndrome: A Cross‑Sectional Clinical Study Zenodo (CERN European Organization for Nuclear Research) · 2026
    18. Plasma Diaphanous Related Formin 1 Levels Are Associated with Altered Glucose Metabolism and Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Case Control Study Mediators of Inflammation · 2022
    19. Study the correlation between Helicobacter pylori and insulin resistance in a group of women with polycystic ovarian syndrome in Baghdad city ASEAN Journal of Psychiatry · 2024
    20. Correlation of skin changes with hormonal changes in polycystic ovarian syndrome: A cross-sectional study clinical study Indian Journal of Dermatology · 2015 · 19 citations
    21. Study of cutaneous manifestations of polycystic ovarian syndrome International journal of reproduction, contraception, obstetrics and gynecology · 2020 · 1 citations
    22. Are STK11 polymorphisms a predictor of the response to metformin in polycystic ovarian syndrome? Biomedical reports · 2022
    23. Current recommendations for the diagnostic evaluation and follow-up of patients presenting with symptomatic polycystic ovary syndrome Best Practice & Research in Clinical Obstetrics & Gynaecology · 2004 · 19 citations
    24. Is early onset androgenic alopecia a marker of metabolic syndrome and carotid artery atherosclerosis in young Indian male patients? International Journal of Trichology · 2015 · 24 citations
    25. Serum Preptin and Amylin Levels with Respect to Body Mass Index in Polycystic Ovary Syndrome Patients Medical Science Monitor · 2018 · 5 citations
    26. A Study of Prevalence of Metabolic Syndrome in Premenopausal Women With Female Pattern Hair Loss: A Case-Control Study Cureus · 2024
    27. The value of the free androgen index depends on the phenotype of polycystic ovary syndrome — a single-centre experience Endokrynologia Polska · 2019 · 7 citations
    28. Evaluation of androgen-dependent skin findings of polycystic ovary syndrome (PCOS) Gynecological Endocrinology · 2022 · 1 citations
    29. Risk factors for androgenetic alopecia: a systematic review and meta-analysis BMC Public Health · 2026
    30. How to Choose the Optimal Starting Dose of Clomiphene Citrate (50 or 100 mg per Day) for a First Cycle of Ovulation Induction in Anovulatory PCOS Women? Journal of Clinical Medicine · 2023